44 results
424B3
ATXI
Avenue Therapeutics Inc
2 Feb 24
Prospectus supplement
12:00am
from bringing a lawsuit against our directors for breach of fiduciary duty. These provisions also may reduce the likelihood of derivative litigation
8-K
EX-10.2
ATXI
Avenue Therapeutics Inc
2 Nov 23
Avenue Therapeutics Announces Pricing of $5.0 Million Public Offering
4:10pm
3.1(hh), there is no pending, completed or, to the Company's knowledge, threatened, action (including any lawsuit, arbitration, or legal
424B4
jus746h5qjdgvtd7of
2 Nov 23
Prospectus supplement with pricing info
9:00am
424B3
xh7g2zz6bkau cv3
28 Jun 23
Prospectus supplement
4:56pm
424B3
041skv4w ozf
4 May 23
Prospectus supplement
4:30pm
424B4
8q9h3unxf7 iqerwutf
11 Oct 22
Prospectus supplement with pricing info
8:27am